What is Jade Biosciences's official website?

Jade Biosciences's website is http://www.jadebiosciences.com

How many employees are working in Jade Biosciences right now?

Jade Biosciences has 51 employees.

What is Jade Biosciences's industry?

Jade Biosciences's industry is Biotechnology Research

Who are Jade Biosciences's top competitors?

Jade Biosciences's top competitors are , , , , , ,

Jade Biosciences company information, Employees & Contact Information

Explore related pages

Jade Biosciences email format Jade Biosciences management contacts

Related company profiles:

Jade Biosciences is developing a pipeline of potentially best-in-class therapies aimed at transforming the standard of care for patients living with autoimmune diseases.

Employees: 51
Founded: -
Address: Jobs
Industry: Biotechnology Research
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)
Website: http://www.jadebiosciences.com
Keywords: Autoimmune and Biotechnology.
Competitors: Kivu Bioscience, Aerovate Therapeutics, Inc., GlycoMimetics, Chimagen Biosciences, Paragon Therapeutics, Inc., Axonis Therapeutics, Crescent Biopharma, Evommune, Ottimo Pharma, Monte Rosa Therapeutics.

Jade Biosciences Questions

News

Jade Biosciences Announces $135 Million Private Placement - Yahoo Finance

Jade Biosciences Announces $135 Million Private Placement Yahoo Finance

Aerovate Therapeutics Stockholders Approve Proposed Merger with Jade Biosciences and All Related Proposals - PR Newswire

Aerovate Therapeutics Stockholders Approve Proposed Merger with Jade Biosciences and All Related Proposals PR Newswire

Jade Biosciences Announces Presentation of Preclinical Data on JADE101 at 62nd European Renal Association Congress - Nasdaq

Jade Biosciences Announces Presentation of Preclinical Data on JADE101 at 62nd European Renal Association Congress Nasdaq

Jade Biosciences to Participate in Upcoming Conferences - Yahoo Finance

Jade Biosciences to Participate in Upcoming Conferences Yahoo Finance

Aerovate Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Jade Biosciences - PR Newswire

Aerovate Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Jade Biosciences PR Newswire

Jade Biosciences, Inc. Completes Reverse Merger, Launches Nasdaq Trading as JBIO, and Secures $300 Million Financing - Nasdaq

Jade Biosciences, Inc. Completes Reverse Merger, Launches Nasdaq Trading as JBIO, and Secures $300 Million Financing Nasdaq

Jade Biosciences Completes Closing of Merger with Aerovate - GlobeNewswire

Jade Biosciences Completes Closing of Merger with Aerovate GlobeNewswire

Jade Biosciences to Participate in the 2025 Jefferies Global Healthcare Conference - Yahoo Finance

Jade Biosciences to Participate in the 2025 Jefferies Global Healthcare Conference Yahoo Finance

Aerovate Therapeutics and Jade Biosciences Merger Approved - citybiz

Aerovate Therapeutics and Jade Biosciences Merger Approved citybiz

Phase 1 interim H1 2026 — Jade Biosciences presents JADE101 preclinical safety & translational posters for IgAN - Stock Titan

Phase 1 interim H1 2026 — Jade Biosciences presents JADE101 preclinical safety & translational posters for IgAN Stock Titan

Jade Biosciences Appoints Brad Dahms as Chief Financial Officer - GlobeNewswire

Jade Biosciences Appoints Brad Dahms as Chief Financial Officer GlobeNewswire

Jade Biosciences Launches with $80 Million to Develop Transformative Therapies for Autoimmune Diseases - PR Newswire

Jade Biosciences Launches with $80 Million to Develop Transformative Therapies for Autoimmune Diseases PR Newswire

Jade Biosciences Presents JADE101 Preclinical Data at the 62nd European Renal Association Congress Demonstrating Potential for Best-in-Class Profile in IgA Nephropathy - Yahoo Finance

Jade Biosciences Presents JADE101 Preclinical Data at the 62nd European Renal Association Congress Demonstrating Potential for Best-in-Class Profile in IgA Nephropathy Yahoo Finance

Aerovate Therapeutics and Jade Biosciences Announce Merger Agreement - Yahoo Finance

Aerovate Therapeutics and Jade Biosciences Announce Merger Agreement Yahoo Finance

Jade Biosciences, Inc. to Participate in H.C. Wainwright and Stifel Biotech Investor Conferences - Nasdaq

Jade Biosciences, Inc. to Participate in H.C. Wainwright and Stifel Biotech Investor Conferences Nasdaq

Jade Biosciences Appoints Tom Frohlich as Chief Executive Officer and Hetal Kocinsky as Chief Medical Officer; Forms Board of Directors and Expands Financing to $95 Million - PR Newswire

Jade Biosciences Appoints Tom Frohlich as Chief Executive Officer and Hetal Kocinsky as Chief Medical Officer; Forms Board of Directors and Expands Financing to $95 Million PR Newswire

Jade Biosciences merges with Aerovate Therapeutics - 07:00:02 29 Apr 2025 - RTW News article - London Stock Exchange

Jade Biosciences merges with Aerovate Therapeutics - 07:00:02 29 Apr 2025 - RTW News article London Stock Exchange

Jade Biosciences raises $80 million for autoimmune work - The Pharma Letter

Jade Biosciences raises $80 million for autoimmune work The Pharma Letter

Institutional investors in Jade Biosciences, Inc. (NASDAQ:JBIO) must be dismayed after prices dropped by 16% last week - Yahoo Finance

Institutional investors in Jade Biosciences, Inc. (NASDAQ:JBIO) must be dismayed after prices dropped by 16% last week Yahoo Finance

JBIO Stock Price and Chart — NASDAQ:JBIO - TradingView

JBIO Stock Price and Chart — NASDAQ:JBIO TradingView

Jade Biosciences closes merger with Aerovate Therapeutics - Business in Vancouver

Jade Biosciences closes merger with Aerovate Therapeutics Business in Vancouver

Jade Biosciences - The Pharma Letter

Jade Biosciences The Pharma Letter

Jade Biosciences Extends Financing; Total To $95M - FinSMEs

Jade Biosciences Extends Financing; Total To $95M FinSMEs

Merger to put biotech Jade Biosciences on Nasdaq - Business in Vancouver

Merger to put biotech Jade Biosciences on Nasdaq Business in Vancouver

Companies like Jade Biosciences

Top Jade Biosciences Employees

Linda Dunlap

Cgmp Document Control | Sharepoint |…

N/a

View
Lori Stewart

n/a

Greater Seattle Area, United States

View

3
adaptivebiotech.com, zones.com, gmail.com

4 +125320XXXXX
Eric Dobmeier

n/a

N/a

View
Alfred Wang

Vice President, Business Development &…

San Francisco Bay Area, United States, United States

View

9
yahoo.com, exelixis.com, gmail.com, aol.com, gateway.net, hotmail.com, verizon.net, gmail.com, chinooktx.com

6 +165080XXXXX

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles

Get direct phone numbers & mobile contacts

Access company data & employee information

Works directly on LinkedIn - no copy/paste needed

Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Learn More

How It Works

Get a Free Account

Search the #1 Contact Database

Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.

Use our AI-Powered Email Finder

Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.

Have a look at Aeroleads Data

Browse our Data

Company Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

Profile Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

List Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

Jade Biosciences company information, Employees & Contact Information

Explore related pages

Company Details

Jade Biosciences Questions

What is Jade Biosciences's official website?

What is Jade Biosciences's LinkedIn profile?

How many employees are working in Jade Biosciences right now?

What is Jade Biosciences's industry?

What are Jade Biosciences's top competitors?

What are Jade Biosciences's categories?

When was Jade Biosciences founded?

News

Jade Biosciences Announces $135 Million Private Placement - Yahoo Finance

Aerovate Therapeutics Stockholders Approve Proposed Merger with Jade Biosciences and All Related Proposals - PR Newswire

Jade Biosciences Announces Presentation of Preclinical Data on JADE101 at 62nd European Renal Association Congress - Nasdaq

Jade Biosciences to Participate in Upcoming Conferences - Yahoo Finance

Aerovate Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Jade Biosciences - PR Newswire

Jade Biosciences, Inc. Completes Reverse Merger, Launches Nasdaq Trading as JBIO, and Secures $300 Million Financing - Nasdaq

Jade Biosciences Completes Closing of Merger with Aerovate - GlobeNewswire

Jade Biosciences to Participate in the 2025 Jefferies Global Healthcare Conference - Yahoo Finance

Aerovate Therapeutics and Jade Biosciences Merger Approved - citybiz

Phase 1 interim H1 2026 — Jade Biosciences presents JADE101 preclinical safety & translational posters for IgAN - Stock Titan

Jade Biosciences Appoints Brad Dahms as Chief Financial Officer - GlobeNewswire

Jade Biosciences Launches with $80 Million to Develop Transformative Therapies for Autoimmune Diseases - PR Newswire

Jade Biosciences Presents JADE101 Preclinical Data at the 62nd European Renal Association Congress Demonstrating Potential for Best-in-Class Profile in IgA Nephropathy - Yahoo Finance

Aerovate Therapeutics and Jade Biosciences Announce Merger Agreement - Yahoo Finance

Jade Biosciences, Inc. to Participate in H.C. Wainwright and Stifel Biotech Investor Conferences - Nasdaq

Jade Biosciences Appoints Tom Frohlich as Chief Executive Officer and Hetal Kocinsky as Chief Medical Officer; Forms Board of Directors and Expands Financing to $95 Million - PR Newswire

Jade Biosciences merges with Aerovate Therapeutics - 07:00:02 29 Apr 2025 - RTW News article - London Stock Exchange

Jade Biosciences raises $80 million for autoimmune work - The Pharma Letter

Institutional investors in Jade Biosciences, Inc. (NASDAQ:JBIO) must be dismayed after prices dropped by 16% last week - Yahoo Finance

JBIO Stock Price and Chart — NASDAQ:JBIO - TradingView

Jade Biosciences closes merger with Aerovate Therapeutics - Business in Vancouver

Jade Biosciences - The Pharma Letter

Jade Biosciences Extends Financing; Total To $95M - FinSMEs

Merger to put biotech Jade Biosciences on Nasdaq - Business in Vancouver

Companies like Jade Biosciences

Monte Rosa Therapeutics

Aerovate Therapeutic...

Chimagen Biosciences

Crescent Biopharma

Axonis Therapeutics

Ottimo Pharma

Kivu Bioscience

Glycomimetics

Evommune

Paragon Therapeutics...

Top Jade Biosciences Employees

Linda Dunlap

Cgmp Document Control | Sharepoint |…

Lori Stewart

n/a

Eric Dobmeier

n/a

Alfred Wang

Vice President, Business Development &…

Free Chrome Extension

Aero Online

Select data to include:

How It Works

Get a Free Account

Search the #1 Contact Database

Use our AI-Powered Email Finder

Have a look at Aeroleads Data